This webinar details how organizations can counter these challenges and become more sophisticated in their drug-related adverse event reporting by adopting state-of-the-art cognitive computing processes into their existing pharmacovigilance management systems. It addresses how cognitive computing technologies can automate a multitude of tasks in pharmacovigilance.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 500 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved
